Total Payments
$4,462
2024 Payments
$96.35
Companies
26
Transactions
153
Medicare Patients
817
Medicare Billing
$239,007
Payment Breakdown by Category
Food & Beverage$4,443 (99.6%)
Education$19.24 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,443 | 148 | 99.6% |
| Education | $19.24 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $1,169 | 58 | $0 (2018) |
| SI-BONE, INC. | $381.85 | 5 | $0 (2021) |
| PFIZER INC. | $366.50 | 16 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $331.78 | 15 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $291.47 | 9 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $267.56 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $242.48 | 4 | $0 (2019) |
| Pacira Pharmaceuticals Incorporated | $171.12 | 2 | $0 (2018) |
| Grifols USA, LLC | $168.76 | 1 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $147.15 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.35 | 1 | VERTEX PHARMACEUTICALS INCORPORATED ($96.35) |
| 2023 | $22.10 | 1 | CSL Behring ($22.10) |
| 2021 | $209.75 | 2 | SI-BONE, INC. ($209.75) |
| 2020 | $159.61 | 2 | SI-BONE, Inc. ($142.28) |
| 2019 | $535.06 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($138.80) |
| 2018 | $1,232 | 41 | Daiichi Sankyo Inc. ($494.22) |
| 2017 | $2,207 | 99 | Daiichi Sankyo Inc. ($675.00) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $96.35 | General |
| 02/07/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/22/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $148.01 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 07/22/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 10/07/2020 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | In-kind items and services | $142.28 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 08/19/2020 | Medtronic Vascular, Inc. | HawkOne (Device) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Directional Atherectomy Devices | ||||||
| 12/10/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $119.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/26/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2019 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/22/2019 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/03/2019 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Addiction Therapy | ||||||
| 01/09/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2018 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $160.32 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2018 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/08/2018 | Grifols USA, LLC | Thrombate III (Biological) | Food and Beverage | In-kind items and services | $168.76 | General |
| Category: Hematology | ||||||
| 11/20/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR ORAL (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2018 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Opioid Induced Constipation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 188 | 662 | $373,250 | $55,674 |
| 2022 | 6 | 196 | 678 | $357,395 | $58,879 |
| 2021 | 6 | 241 | 741 | $401,585 | $64,987 |
| 2020 | 5 | 192 | 655 | $406,190 | $59,467 |
Total Patients
817
Total Services
2,736
Medicare Billing
$239,007
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 487 | $216,715 | $36,549 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 137 | $85,625 | $15,003 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $18,800 | $2,617 | 13.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 12 | 18 | $52,110 | $1,506 | 2.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 456 | $191,440 | $34,784 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 131 | $77,915 | $14,871 | 19.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 47 | $26,085 | $5,043 | 19.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $12,530 | $1,874 | 15.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 11 | 15 | $41,325 | $1,323 | 3.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 15 | $8,100 | $984.30 | 12.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 88 | 483 | $193,200 | $39,213 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 102 | $57,630 | $10,480 | 18.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 73 | $38,325 | $8,541 | 22.3% |
| 01996 | Daily hospital management of continuous spinal drug administration | Facility | 2021 | 48 | 48 | $47,280 | $2,828 | 6.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $12,750 | $2,079 | 16.3% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2021 | 16 | 20 | $52,400 | $1,846 | 3.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 541 | $289,435 | $49,520 | 17.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 37 | $18,500 | $3,770 | 20.4% |
| 01996 | Daily hospital management of continuous spinal drug administration | Facility | 2020 | 45 | 45 | $42,075 | $2,690 | 6.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $11,270 | $1,901 | 16.9% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2020 | 15 | 18 | $44,910 | $1,587 | 3.5% |
About Dr. David Wang, M.D
Dr. David Wang, M.D is a Acupuncturist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154374817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wang, M.D has received a total of $4,462 in payments from pharmaceutical and medical device companies, with $96.35 received in 2024. These payments were reported across 153 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,443).
As a Medicare-enrolled provider, Wang has provided services to 817 Medicare beneficiaries, totaling 2,736 services with total Medicare billing of $239,007. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Acupuncturist
- Other Specialties Anesthesiology, Interventional Pain Medicine
- Location New York, NY
- Active Since 05/17/2006
- Last Updated 05/19/2023
- Taxonomy Code 171100000X
- Entity Type Individual
- NPI Number 1154374817
Products in Payments
- Movantik (Drug) $943.05
- RELISTOR (Drug) $346.17
- Xtampza ER (Drug) $270.78
- Morphabond ER (Drug) $226.17
- RELISTOR ORAL (Drug) $212.86
- IFUSE IMPLANT (Device) $209.75
- iFuse Implant (Device) $172.10
- EXPAREL (Drug) $171.12
- Thrombate III (Biological) $168.76
- LYRICA (Drug) $166.45
- INFINION (Device) $147.15
- LOKELMA (Drug) $125.00
- BELBUCA (Drug) $124.99
- INVOKANA (Drug) $119.02
- SCS IPGs (Device) $116.94
- HYSINGLA ER (Drug) $87.27
- ADAPTIVESTIM (Device) $75.79
- Horizant (Drug) $55.59
- Amitiza (Drug) $49.61
- FLECTOR PATCH (Drug) $47.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acupuncturist Doctors in New York
Mr. Alexander Rances, D.o, D.O
Acupuncturist — Payments: $18,406
Acupuncturist $18,406
Dr. Michael Flamm, D.o, D.O
Acupuncturist — Payments: $4,699
Acupuncturist $4,699
Rachel Bergang, Md, MD
Acupuncturist — Payments: $3,300
Acupuncturist $3,300
Dr. David Kamlet, M.d, M.D
Acupuncturist — Payments: $2,353
Acupuncturist $2,353
Inna Revutsky
Acupuncturist — Payments: $674.30
Acupuncturist $674.30
Dr. Frank Lipman, M.d, M.D
Acupuncturist — Payments: $99.52
Acupuncturist $99.52